Market Cap 699.68M
Revenue (ttm) 42.07M
Net Income (ttm) -130.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -309.72%
Debt to Equity Ratio 0.00
Volume 3,189,200
Avg Vol 3,591,494
Day's Range N/A - N/A
Shares Out 108.39M
Stochastic %K 16%
Beta 1.63
Analysts Strong Sell
Price Target $10.43

Company Profile

Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repress...

Industry: Biotechnology
Sector: Healthcare
Phone: 857 320 4900
Address:
201 Brookline Avenue, Suite 901, Boston, United States
biolover
biolover Jul. 18 at 10:17 PM
$TNGX F13 black rock now has > 5 % of tango. I didn’t expect general funds as driving this rally. It is interesting
2 · Reply
Chauncy_Peppertooth
Chauncy_Peppertooth Jul. 18 at 2:14 PM
$TNGX that’s how you know it’s a good one :)
0 · Reply
Pepecola
Pepecola Jul. 18 at 2:10 PM
$TNGX such an interesting stock..im up over 200%..its the quietest up 200% low cap stock iver ever been in lol
0 · Reply
Chauncy_Peppertooth
Chauncy_Peppertooth Jul. 18 at 2:06 PM
0 · Reply
Rush4040
Rush4040 Jul. 17 at 7:22 PM
$TNGX DONT MISS OUT!!!!
0 · Reply
biolover
biolover Jul. 17 at 5:20 PM
$TNGX pts data leak or partnership. ( ceo talked about partnership discussion in sep ). This company leaks.
0 · Reply
LabPsycho
LabPsycho Jul. 17 at 4:56 PM
$TNGX There is a reason...or I hope there is, why I invested so much time in setting up the below simulation. I have to say the authors of that paper / impressive. I still stand by my several weeks ago thought when this popped from 1.4 to 2, the retraced and recovered...something triggered that. Wild and probably erroneous explanation but possible patient data leak? How else to explain now $700M market cap?
0 · Reply
Chauncy_Peppertooth
Chauncy_Peppertooth Jul. 17 at 1:49 PM
0 · Reply
biolover
biolover Jul. 11 at 6:13 PM
$TNGX they can’t keep it down. Sneaky CEO lady must have leaked something. That is not nl
0 · Reply
biolover
biolover Jul. 11 at 3:17 PM
$VKTX look at $TNGX it emerged from $1 SP to $6 last 4-6 wks and short interest peaked to 53% to slow this explosive recovery. They are shorting a small biotech who will have a novel treatment that covers 10-15% of all cancers. They are not geniuses .. some of it hedging but can’t be that high. Both primed for epic short squeeze
0 · Reply
Latest News on TNGX
Tango Therapeutics: Chance For A Short Squeeze

Jan 23, 2025, 5:44 AM EST - 6 months ago

Tango Therapeutics: Chance For A Short Squeeze


Tango Therapeutics to stop development of cancer therapy

May 23, 2024, 7:19 AM EDT - 1 year ago

Tango Therapeutics to stop development of cancer therapy


Circling Bank On Tango Therapeutics

Oct 23, 2023, 6:26 PM EDT - 1 year ago

Circling Bank On Tango Therapeutics


Tango Therapeutics Announces Updates to Its Board of Directors

Aug 29, 2023, 5:08 PM EDT - 2 years ago

Tango Therapeutics Announces Updates to Its Board of Directors


Tango Therapeutics: Partial Phase 1 Data Has Not Helped

Jul 26, 2023, 7:29 PM EDT - 2 years ago

Tango Therapeutics: Partial Phase 1 Data Has Not Helped


Tango Therapeutics: Behind The Recent Momentum

Nov 14, 2022, 4:11 PM EST - 2 years ago

Tango Therapeutics: Behind The Recent Momentum


biolover
biolover Jul. 18 at 10:17 PM
$TNGX F13 black rock now has > 5 % of tango. I didn’t expect general funds as driving this rally. It is interesting
2 · Reply
Chauncy_Peppertooth
Chauncy_Peppertooth Jul. 18 at 2:14 PM
$TNGX that’s how you know it’s a good one :)
0 · Reply
Pepecola
Pepecola Jul. 18 at 2:10 PM
$TNGX such an interesting stock..im up over 200%..its the quietest up 200% low cap stock iver ever been in lol
0 · Reply
Chauncy_Peppertooth
Chauncy_Peppertooth Jul. 18 at 2:06 PM
0 · Reply
Rush4040
Rush4040 Jul. 17 at 7:22 PM
$TNGX DONT MISS OUT!!!!
0 · Reply
biolover
biolover Jul. 17 at 5:20 PM
$TNGX pts data leak or partnership. ( ceo talked about partnership discussion in sep ). This company leaks.
0 · Reply
LabPsycho
LabPsycho Jul. 17 at 4:56 PM
$TNGX There is a reason...or I hope there is, why I invested so much time in setting up the below simulation. I have to say the authors of that paper / impressive. I still stand by my several weeks ago thought when this popped from 1.4 to 2, the retraced and recovered...something triggered that. Wild and probably erroneous explanation but possible patient data leak? How else to explain now $700M market cap?
0 · Reply
Chauncy_Peppertooth
Chauncy_Peppertooth Jul. 17 at 1:49 PM
0 · Reply
biolover
biolover Jul. 11 at 6:13 PM
$TNGX they can’t keep it down. Sneaky CEO lady must have leaked something. That is not nl
0 · Reply
biolover
biolover Jul. 11 at 3:17 PM
$VKTX look at $TNGX it emerged from $1 SP to $6 last 4-6 wks and short interest peaked to 53% to slow this explosive recovery. They are shorting a small biotech who will have a novel treatment that covers 10-15% of all cancers. They are not geniuses .. some of it hedging but can’t be that high. Both primed for epic short squeeze
0 · Reply
biolover
biolover Jul. 10 at 9:24 PM
$TNGX Despite meteoric recovery $TNGX short interest now stands at 50%. Not sure how much of that is hedging, but this would be a class case of short squeeze with data disclosure soon.
2 · Reply
SadyK189
SadyK189 Jul. 10 at 2:11 AM
$TNGX Alerted at 4.35. Currently at 6.06. Still trending nicely on daily chart. Updated key support at 4.40 - 4.80. Next key level to test is 6.75 - 7.10. It moves slowly and steadily
0 · Reply
HuntingBenjmins
HuntingBenjmins Jul. 9 at 5:36 PM
$TNGX I see this thing is still running like magic. A very interesting stock. Most need some news to more than quadruple in price. This thing here? Just because it feels like it. I got a few others that I’m holding that could use some of what TNGX has been smoking. Was a great buy at $1.08 not that long ago.
0 · Reply
LabPsycho
LabPsycho Jul. 9 at 4:54 PM
$CCCC Could this run like $TNGX from $1.3 to $6 in just a few weeks ? I see several similarities between CCCC and TNGX
2 · Reply
Rush4040
Rush4040 Jul. 9 at 2:08 PM
$TNGX easy money
0 · Reply
CPKC
CPKC Jul. 8 at 9:28 PM
$TNGX so quiet here
0 · Reply
Quantumup
Quantumup Jul. 8 at 12:26 PM
Ladenburg Thalmann🏁 $ORIC Buy-$15. $PFE $ALPMY $AMGN $TNGX Ladenburg Thalmann said in its research report: "Initiating coverage of $ORIC with a Buy rating and $15 price target based on 1) emerging profile of the PRC2 inhibitor ORIC-944 as a potential fast-follower to mevrometostat in treatment AR-experienced mCRPC, 2) strategic pivot for development of ORIC-114 from 2nd-line exon 20 EGFR/HER2 tumors to the 1st-line representing a larger addressable population and opportunity to maximize clinical differentiation based on potential best-in-class CNS activity and 3) experienced management team with a track record of guiding targeted cancer drugs through clinical development."
0 · Reply
LabPsycho
LabPsycho Jul. 2 at 6:28 PM
$TNGX How to explain TNGX $600M market cap, more than 300% increase in ~ a month, few pumpers on this board, and an impressive chart? See below is one hypothesis, but any one else have any other wild speculations?
0 · Reply
prismmarketview
prismmarketview Jun. 30 at 2:24 PM
$TNGX https://prismmarketview.com/new-tango-trial-targets-toughest-cancers-with-precision-combo-therapy/
0 · Reply
LabPsycho
LabPsycho Jun. 27 at 11:05 PM
$TNGX Shown below is my Molecular Dynamic Simulation of TNG462 bound to PRMT5·MTA . Molecular ensemble built in part from X-ray crystal structure of TNG908 & TNG462 bound to PRMT5·MTA PDB ID: 8VEY 9N3Q. References: J. Med. Chem. 2025, 68, 5, 5097–5119. Molecular ensemble built in part using VMD, Colab, Openmm, Alpha Fold, Python, SwissParam and LabPsycho’s Artificial Artificial IntelligenceTM (A.^2 I.) This simulation highlights the dynamic interaction between the rotating N-methylpiperidine of TNG462 with the acid of Glu320 via a salt bridge. If you like this kind of stuff go (what's the purpose!?) check out my recent simulation of C4 Therapeutics $CCCC molecular glue. Methodology described in more detail in the YouTube video posted on the CCCC board that was also used there.
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jun. 27 at 11:15 AM
$TNGX Tango Therapeutics Doses First Patient In Phase 1/2 Combo Trial With Revolution Medicines' RAS Inhibitors For MTAP-Deleted Cancers
0 · Reply
_www_larval_com_
_www_larval_com_ Jun. 25 at 7:53 PM
$SAFX -7%[26%] $NXTT -3%[9%] $XFOR -3%[-10%] $PRTG 3%[19%] $TNGX -3%[-9%] most notable movement into the final minutes of trading.
0 · Reply